LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 10.46 | 27.76 | 1 | 438 | 0.0023 | -0.5660 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 10.46 | 27.76 | 854 | 438 | 1.9469 | 1.3642 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 10.46 | 27.76 | 1 | 438 | 0.0023 | -0.5660 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 10.46 | 27.76 | 673 | 438 | 1.5343 | 1.2270 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 12.17 | 27.76 | 4 | 489 | 0.0082 | -0.3738 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 12.17 | 27.76 | 909 | 489 | 1.8586 | 1.3231 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 12.17 | 27.76 | 1 | 489 | 0.0020 | -0.5520 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 12.17 | 27.76 | 715 | 489 | 1.4620 | 1.1922 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 13.87 | 27.76 | 2 | 604 | 0.0033 | -0.4466 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 13.87 | 27.76 | 976 | 604 | 1.6140 | 1.2274 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 13.87 | 27.76 | 1 | 604 | 0.0017 | -0.5265 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 13.87 | 27.76 | 778 | 604 | 1.2866 | 1.1166 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 15.58 | 27.76 | 5 | 685 | 0.0073 | -0.3096 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 15.58 | 27.76 | 1034 | 685 | 1.5082 | 1.1858 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 15.58 | 27.76 | 1 | 685 | 0.0015 | -0.5125 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 15.58 | 27.76 | 871 | 685 | 1.2705 | 1.1062 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 17.28 | 27.76 | 2 | 838 | 0.0024 | -0.4143 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 17.28 | 27.76 | 1133 | 838 | 1.3509 | 1.1261 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 17.28 | 27.76 | 8 | 838 | 0.0095 | -0.2235 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 17.28 | 27.76 | 957 | 838 | 1.1410 | 1.0544 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 18.98 | 27.76 | 7 | 941 | 0.0074 | -0.2374 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 18.98 | 27.76 | 1213 | 941 | 1.2889 | 1.1024 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 18.98 | 27.76 | 12 | 941 | 0.0128 | -0.1521 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 18.98 | 27.76 | 1046 | 941 | 1.1114 | 1.0420 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 20.68 | 27.76 | 15 | 1119 | 0.0134 | -0.1090 | MN20160318_Q01 | C19 |